Direct cell-cell contact between Mesenchymal Stem Cells and Endothelial Progenitor Cells induces a Pericyte-like phenotype in vitro by Loibl, Markus et al.
Research Article
Direct Cell-Cell Contact between Mesenchymal Stem Cells and
Endothelial Progenitor Cells Induces a Pericyte-Like Phenotype
In Vitro
Markus Loibl,1,2 Andreas Binder,1,2 Marietta Herrmann,1 Fabian Duttenhoefer,1,3
R. Geoff Richards,1 Michael Nerlich,2 Mauro Alini,1 and Sophie Verrier1
1 AO Research Institute Davos, Clavadelerstrasse 8, 7270 Davos, Switzerland
2Department of Trauma Surgery, Regensburg University Medical Center, 93042 Regensburg, Germany
3Department of Oral and Maxillofacial Surgery, Albert-Ludwigs-University, 79106 Freiburg, Germany
Correspondence should be addressed to Sophie Verrier; sophie.verrier@aofoundation.org
Received 4 October 2013; Revised 24 November 2013; Accepted 15 December 2013; Published 20 January 2014
Academic Editor: Sanga Gehmert
Copyright © 2014 Markus Loibl et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Tissue engineering techniques for the regeneration of large bone defects require sufficient vascularisation of the applied constructs
to ensure a sufficient supply of oxygen and nutrients. In our previous work, prevascularised 3D scaffolds have been successfully
established by coculture of bonemarrowderived stem cells (MSCs) and endothelial progenitor cells (EPCs).We identified stabilising
pericytes (PCs) as part of newly formed capillary-like structures. In the present study, we report preliminary data on the interactions
between MSCs and EPCs, leading to the differentiation of pericyte-like cells. MSCs and EPCs were seeded in transwell cultures,
direct cocultures, and single cultures. Cells were cultured for 10 days in IMDM 10% FCS or IMDM 5% FCS 5% platelet lysate
medium. Gene expression of PC markers, CD146, NG2, 𝛼SMA, and PDGFR-𝛽, was analysed using RT-PCR at days 0, 3, 7, and 10.
The upregulation of CD146, NG2, and 𝛼SMA inMSCs in direct coculture with EPCs advocates the MSCs’ differentiation towards a
pericyte-like phenotype in vitro.These results suggest that pericyte-like cells derive fromMSCs and that cell-cell contact with EPCs
is an important factor for this differentiation process. These findings emphasise the concept of coculture strategies to promote
angiogenesis for cell-based tissue engineered bone grafts.
1. Introduction
The remarkable regeneration potential of bone tissue is based
on the presence of a highly branched vessel network, provid-
ing oxygen, nutrients, growth factors, and precursor cells to
the injured tissue [1]. However, the capacity of regeneration is
limited and fails in large bone defects.Thus, the gold-standard
strategy remains autologous bone implants, associated with
an additional surgical procedure at the harvesting site causing
an increase of operation time, pain, and risk for infection at
the donor site.
Cell-based tissue engineering strategies have been devel-
oped and are accepted since a few years to address the
challenge of bone repair. The approach of engineering bone
tissue not only depends on the presence of osteogenic cells
at the healing site but also requires an adequate vascularisa-
tion of the applied biomaterial [2]. Therefore, bone-forming
osteoblasts and endothelial cells (or their progenitors) are
playing a crucial role for successful engraftment of cell seeded
biomaterials [3].
Bone marrow is a natural reservoir of mesenchymal
stem cells (MSCs) able to develop an osteogenic, chon-
drogenic, and adipogenic phenotype upon stimulation. The
recruitment, growth, and differentiation ofMSCs intomature
osteoblasts are regulated by many cytokines and growth fac-
tors. These factors are secreted not only by the osteoblasts
themselves, but also from endothelial cells from the tightly
connected vascular network [2, 4, 5]. This crosstalk between
different cell types is enabled by secreted paracrine factors, as
well as by direct cell-to-cell interactions.
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In 1997, Asahara et al. identified the presence of bone
marrow derived endothelial progenitor cells (EPCs) able to
develop an endothelial phenotype in peripheral blood of
adults.Those progenitor cells are known to express CD34 [6],
CD133 [7], and CD309 [8] and as mature endothelial cells,
they specifically bind UEA-1 lectins [7, 9]. As they are present
in the blood compartment as well as in the bonemarrow, they
can easily be isolated in an autologous way, which is a funda-
mental advantage for further tissue engineering applications.
Recently, we developed an in vitro prevascularised 3D
polyurethane (PU) bone implant seeded with EPCs (CD34+/
CD133+) and MSCs, which showed the formation of luminal
tubular structures after 7 days of coculture [10]. These cap-
illary-like structures expressed not only mature endothe-
lial cell markers (i.e., PECAM-1, vWF), but also pericyte
(PC) markers (i.e., CD146, NG2, and 𝛼SMA). PCs are still
poorly characterised [11] and their reported markers are also
expressed on other cells associated with blood vessels [11, 12].
Coexpression of several markers (CD146 [13, 14], NG2 [15],
𝛼SMA [16], and PDGFR-𝛽 [17]) and absence of endothelial
markers (PECAM-1) [7] may be used to identify PCs in vitro.
However, coexpression of these markers by PCs is variable
and depends not only on the tissue of origin [18], but also
on culture conditions [19]. Hellstro¨m et al. [20] and more
recently Blocki et al. suggested that PCs represent a subpopu-
lation of MSCs in bone marrow, contributing to microvessel
maturation, stability, structure, and function [19, 20]. PCs
establish important direct cell-cell contact with endothe-
lial cells of immature blood vessels [21] and some studies
suggested that PCs may serve as guiding structures aiding
outgrowth of endothelial cells to form early capillary sprouts
[22].
Based on our previous findings concerning the partic-
ipation of PC-like cells in the overall structure of in vitro
preformed capillary network [10], the aimof the present study
was to determine the origin of PC-like cells in cocultures of
MSCs andEPCs in vitro.We analysed the influence of cell-cell
interactions in two different 2D coculture systems. In addi-
tion, two cell culture media were tested; on one hand, cells
were cultured in a classical cell culture medium without any
growth factor supplements; on the other hand, the medium
was supplemented with autologous platelet lysate growth
factors (PL) to provide the optimal condition for EPCs [23].
2. Materials and Methods
2.1. Preparation of Platelet Lysate Growth Factors (PL). PLwas
prepared from platelet concentrates, as described earlier [23].
Platelet bags were obtained from the blood bank of Kanton-
sspital Graubu¨nden in Chur in accordance with the current
ethical laws of Switzerland.Theplatelet bags contained a stan-
dardised platelet density (5 times above physiological con-
centration), obtained by blood apheresis. The platelet density
was further increased by a centrifugation at 2000 g for 20
minutes. After two washing steps in phosphate buffer saline
(PBS) and subsequent centrifugation, the platelet pellets were
resuspended in half of the original volume of PBS to obtain
a final density 10 times higher than that in normal blood
(2.5 million (±10%) platelets/𝜇L). PL samples were pooled
from platelet concentrates from three different donors and
randomly matched.
2.2. Bone Marrow Aspirates. Human bone marrow aspirates
(20mL) were obtained upon informed consent and ethical
approval (EK Regensburg 12-101-0127) from 6 donors under-
going routine orthopaedic surgery (20 to 76 years old, average
age 43 years; 4 females and 2 males). The samples were
processed within 24 hours after harvesting.
2.3. Mesenchymal Stem Cells (MSC). Bone marrowmononu-
cleated cells (BMCs) were isolated from bone marrow aspi-
rates by Histopaque-1077 (Sigma-Aldrich) density gradient
centrifugation, as previously described [24]. Briefly, bone
marrow was homogenised and diluted 1 : 4 with PBS. After
slowly pipetting onHistopaque, the samples were centrifuged
at 800 g for 20 minutes.The interphase containing BMCs was
collected and washed twice in Iscove Modified Dulbecco
Medium (IMDM, Gibco) containing 10% human MSC qual-
ified fetal calf serum (FCS, Gibco), followed by 15min cen-
trifugation at 400 g. BMCs were seeded at the density of 16 ×
106 mononucleated cells per 300 cm2 cell culture flask (BD
Biosciences, Falcon Cell Culture Dishes) and cultured in
MinimumEssentialMediumAlpha (MEM𝛼, Gibco) contain-
ing PenStrep (PS) (100U/mL, Gibco), 10% FCS, and 5 ng/mL
basic fibroblast growth factor (bFGF) (R&D Systems). After
the first passage, adhesion selected MSCs were further sub-
cultured at a density of 0.9× 106 per 300 cm2 cell culture flask.
2.4. Endothelial Progenitor Cells (EPC) and CD34-CD133-
CD146-Depleted MSCs (Depleted-MSCs). CD34+, CD133+,
and CD146+ cell populations were further selected from the
previously isolated BMCs using magnetic microbeads linked
to antibodies specific to CD133, CD34, or CD146 (MACS sys-
tem, Miltenyi Biotec) according to the manufacturer instruc-
tions. After isolation, the different cell populations were
referred to as CD133+, CD34+, or CD146+, respectively. The
remaining cell population (depleted from CD133+, CD34+,
and CD146+ cells) was termed depleted-MSCs. CD34+ and
CD133+ cells were pooled and from then on referred to
as EPCs. Cells from the depleted-MSCs population were
propagated in MEM𝛼 containing PS (100U/mL), 10% FCS,
and 5 ng/mL bFGF. EPCs were cultured in IMDM containing
PS (100U/mL), supplemented with 5% PL, 5% FCS, and 1%
nonessential amino acids (NEAA, Gibco). All cell types were
cultured at 37∘C 5% CO
2
humidified atmosphere incubator
and media were changed twice a week.
2.5. Cell Culture. For all subsequent experiments, cells
between passages 2 and 3 were used. MSCs, depleted-MSCs,
and EPCs (CD34+/CD133+) were enzymatically detached
(Trypsin-EDTA), counted, seeded at a density of 5,000
cells/cm2 in 3 different culture setups (Figure 1), and incu-
bated for 3, 7, or 10 days in presence of IMDM-FCS (IMDM
supplemented with 10% FCS and 1% NEAA) or IMDM-PL
(IMDM supplemented with 5% FCS, 5% PL, and 1% NEAA).
For indirect cocultures (transwell), MSCs (or depleted-
MSCs) were seeded in the bottom part of 6-well plates
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Figure 1: Cell culture setups.MSCs or depleted-MSCs were seeded with EPCs in transwell culture (a) or direct coculture (b).MSCs, depleted-
MSCs, and EPCs were seeded in single cultures (c) as controls. All experiments were performed in the presence of IMDM-FCS (IMDM
supplemented with 10% FCS) or IMDM-PL (IMDM supplemented with 5% FCS, 5% PL).
at a density of 5,000 cells/cm2 for transwell culture setup
(Figure 1(a)), whereas EPCs were seeded at the same density
in the corresponding transwell cell culture inserts (0.4 𝜇m
pore size, Sigma-Aldrich).
For direct coculture experiments (direct coculture),
MSCs and EPCs, as well as depleted-MSCs and EPCs, were
coseeded in a 1 : 1 ratio in 75 cm2 cell culture plate (BD Bio-
sciences) at an initial density of 5,000 cells/cm2 (Figure 1(b)).
In addition, each cell type was seeded individually in 6-
well plates (5,000 cells/cm2) for single culture as controls
(Figure 1(c)).
2.6. Cell Sorting. Prior to gene expression analysis, cells in
direct cocultures were separated by fluorescence activated cell
sorting (FACS) using FITC labelled lectin (UEA-1, Sigma-
Aldrich) which specifically labels EPCs. Adherent cells were
incubated for 60 minutes at 37∘C in the dark with 10 𝜇g/mL
FITC-lectin in IMDM-FCS as previously described [7].
Afterwards, cells were washed three times with PBS and
trypsinised, followed by centrifugation at 2000 g for 10min.
The resulting cell pellet was resuspended in 500 𝜇L PBS 1%
FCS, filtered through a 40𝜇m cell strainer, and subjected to
FACS analysis (FACSAria III, BD Biosciences). FITC signal
was identified with a 488 nm excitation laser and 502LP filter.
Cell analysis was performed on at least 10,000 events for each
sample and analysed using FACS DIVA software version 6.1.3
(BD Biosciences). A primary gate based on physical param-
eters (forward and side scatter) was set to exclude dead cells
or small debris. For the separation, gating was implemented
based on the negative-control staining profile of MSCs in
direct coculture with EPCs. Sorting gates were determined
by fluorescence intensity of FITC maintaining a gap between
the lectin negative and the lectin positive gate. Cells were
fractionated with an efficiency of >90% in lectin positive
and lectin negative cell populations and collected in PBS 1%
FCS.The lectin positive cell population represents EPCs, and
the lectin negative population represents MSCs or depleted-
MSCs. At least 50,000 events per sorted cell type were col-
lected. After separation, cells were spin down andmRNAwas
extracted for further analysis. In parallel, the sorted cell
populations were reseeded (1 : 1 ratio) onto a 2-well glass slide
(LabTek chamber slides, Thermo Fisher scientific) at 5,000
cells per cm2 for immunofluorescence staining.
2.7. Real-Time PCR. At days 3, 7, and 10, total RNA was
extracted from monolayers or sorted cells using Tri Reagent
(Molecular Research Centre, Inc.) according to the manu-
facturer’s protocol and stored at −80∘C until further use.
cDNA was synthesised from 1𝜇g RNA using TaqMan reverse
transcription reagents (Applied Biosystems, Invitrogen) with
MultiScribe reverse transcriptase (50U/𝜇L) and randomhex-
amer primers. Real-time Polymerase chain reaction (PCR)
was performed on the StepOne Plus machine (Applied
Biosystems). Genes of interest were detected using CD146/
MCAM (HS00174838 m1), NG2/CSPG4 (HS00426981 m1),
𝛼SMA/ACTA2 (HS00909449 m1), PECAM-I (HS01065282
m1), and PDGFR-𝛽 (HS00182163 m1) all purchased from
Applied Biosystems. Human GAPDH (Cat no. 4326317E,
Applied Biosystems) was used as a housekeeping gene. PCR
conditions were 95∘C for 10min, followed by 45 cycles of
amplification at 95∘C for 15 sec and 60∘C for 1min using
the Stepone software v2.1 (Applied Biosystems). Relative
quantification of mRNA targets was performed according to
the comparative ΔΔCt method.
2.8. Immunocytochemistry. After 7 days of cell culture in
IMDM-FCS or IMDM-PL, cells were separated and seeded
onto LabTek chamber slides. Cells were allowed to adhere
for at least 6 hours prior to fixation with 70% methanol for
10 minutes and 100% methanol for 2 minutes and stored at
−20∘C until further use. Cells were rehydrated in PBS prior
to staining procedure. Nonspecific bindings were blocked
by incubation with 5% normal goat serum (Vector Labs)
in PBS for 60 minutes. Thereafter, slides were incubated
with a mouse anti-human antibody (anti-hCD146 (clone
P1H12, ab24577) or anti-hNG2 (clone LHM2, ab20156)) and
a rabbit anti-human antibody (anti-hNG2 (ab104535) or
anti-h𝛼SMA (ab5694)) simultaneously. Mouse anti-human
and rabbit anti-human antibodies were used in 3 different
combinations: CD146/NG2, CD146/𝛼SMA, andNG2/𝛼SMA.
After 1 h of incubation at room temperature, the samples
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Figure 2: Baseline gene expression at day 0 ofMSCs, depleted-MSCs, and EPCs (ΔCt values relative to GAPDH in logarithmic scale). Pericyte
marker genes (CD146, NG2, 𝛼SMA, and PDGFR-𝛽) and an endothelial marker gene (PECAM-1) were detected in MSCs (a), depleted-MSCs
(b), and EPCs (c) after single culture in culture medium at day 0 in 5 independent experiments.
were washed and stained with corresponding secondary flu-
orescent antibodies: Alexa Fluor 488 conjugated anti-mouse
antibody (Life Technologies, A11029) and TRITC conjugated
anti-rabbit antibody (abcam, ab50598).
Primary and secondary antibodies were both incubated
for 1 hour at room temperature. Stained slides were cover-
slipped with Prolong Gold Antifade reagent with DAPI
(Molecular Probes, Life Technologies). A digital image was
obtained by using an AxioCam HRc camera and AxioVision
software V3.1 (Carl Zeiss).
2.9. Statistical Analysis. Results are presented as mean ±
standard error of themean. Statistical analysis was performed
using Prism 4 software (Graphpad). One-way ANOVA with
Tukey’s multiple comparison test was used to calculate the
overall differences in nonsize matched experimental groups.
Level of significance was 𝑃 < 0.05.
3. Results
3.1. Cell Characterisation. The baseline expression of the per-
icyte and endothelial marker genes in each of the 3 tested
cell populations (MSCs, depleted-MSCs, andEPCs)wasmea-
sured prior to exposure to the different culture conditions
(day 0) using GAPDH as a housekeeping gene. Similar
expression profile was observed on day 0 for the MSCs and
depleted-MSCs populations when propagated in MEM𝛼
supplemented with 10% FCS and 5 ng/mL bFGF (Figures 2(a)
and 2(b)). Moreover, 𝛼SMA and PDGFR-𝛽 were expressed
at a higher level compared to CD146 and NG2 in MSCs and
depleted-MSCs, without a significant difference (𝑃 > 0.05).
However, as expected PECAM-1 was expressed at a lower
level than the PC marker genes.
A similar trend of baseline gene expression was observed
for EPCs population after culturing in IMDM supplemented
with 5% FCS and 5% PL, without a significant difference for
all tested genes (𝑃 > 0.05). The endothelial marker PECAM-
1 was expressed at a lower level than the PC marker genes
similar to MSCs and depleted-MSCs.
3.2. Influence of Cell Culture Setups on Gene Expression.
Gene expression analysis of MSCs cultured in IMDM-FCS
revealed an upregulation of CD146 (Figure 3(a)) for all time
points and all cell media when compared to day 0. Repre-
sentative data are shown for day 3 and are summarised in
Supplementary Table 1 (see Supplementary Material avail-
able online at http://dx.doi.org/10.1155/2014/395781). CD146
expression demonstrated a 15.1±6.99-fold increase compared
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Figure 3: Gene regulation in MSCs and EPCs after 3 days of culture in IMDM-FCS. Pericyte marker genes CD146 ((a), (f)), NG2 ((b), (g)),
𝛼SMA ((c), (h)), and PDGFR-𝛽 ((d), (i)) and endothelial marker gene PECAM-1 ((e), (j)) were detected in MSCs and EPCs after 3 days in
transwell culture, direct coculture, and single culture in IMDM-FCS (IMDM supplemented with 10% FCS). Results are presented for each
gene as relative change in gene expression (2−ΔΔCt) over time between day 0 and day 3 in 5 independent experiments (donor 1–5) and as
average ± error of the mean of all experiments.
6 BioMed Research International
to day 0 in coculture and a 3.25 ± 0.89- and 1.97 ± 0.58-
fold increase in single and transwell culture, respectively
(Figure 3(a)). A similar trend was detected for NG2 but to a
lesser extent. NG2 expression demonstrated a 6.4 ± 2.6-fold
increase compared to day 0 in coculture and a 3.21 ± 0.36-
and 2.06 ± 0.21-fold increases in single and transwell culture,
respectively (Figure 3(b)). An overall decrease of 𝛼SMA and
PDGFR-𝛽 expression was observed for MSCs, with a lower
extent for the direct coculture condition (Figures 3(c) and
3(d)). The expression of PECAM-1 was decreased in MSC
in all culture conditions and at all time points (Figure 3(e)).
A similar trend of gene expression was shown for depleted-
MSCs (Supplementary Figure 1).
Analysis of EPCs revealed an increasedCD146 expression
in all culture setups. In contrast to MSC, direct coculture
induced the lowest level of upregulation (2−ΔΔCt2.42 ± 0.78,
Figure 3(f)). A similar trend was apparent for NG2 but to a
lesser extent (Figure 3(g)).
The 𝛼SMA expression showed a constant decrease in
single culture or transwell culture (2−ΔΔCt0.63 ± 0.1 and
2
−ΔΔCt
0.58 ± 0.07, resp.). However, EPCs in direct coculture
with MSC demonstrated no change in 𝛼SMA expression
(2−ΔΔCt0.97 ± 0.2) (Figure 3(h)). The PDGFR-𝛽 expression
showed a marginal increase in direct coculture with MSCs
(2−ΔΔCt1.46±0.27) (except donor 1), a minor increase in tran-
swell culture (2−ΔΔCt1.35 ± 0.65) (except donor 4), and no
changes in gene expression in single culture (Figure 3(i)).
Of interest, a significant upregulation of PECAM-1 was
observed in EPCs (2−ΔΔCt8.16 ± 3.49) when cocultured in
direct cell-cell contact with MSCs in comparison to single or
transwell culture (2−ΔΔCt0.26 ± 0.08 and 2−ΔΔCt0.21 ± 0.09)
(Figure 3(j)).
EPC gene expression in all culture setups revealed similar
trends when EPCs were cocultured with depleted-MSCs
(Supplementary Figure 1).
3.3. Influence of Culture Medium on Gene Expression. Gene
expression analysis of MSCs, depleted-MSCs, and EPCs cul-
tured in IMDM-PL (Figure 4 and Supplementary Figure 2)
revealed the same trend of changes as for IMDM-FCS at
all time points. Representative data are presented for day 3
(Figure 4 and Supplementary Figure 2). However, the differ-
ences between the cell culture conditions were less prominent
as detected for IMDM-FCS medium. Similar to IMDM-
FCS, highest upregulation of CD146 and NG2 expression was
detected inMSCs in direct coculture with EPCs (Figures 4(a)
and 4(b)). CD146 expression demonstrated a 8.44 ± 3.5-fold
increase in direct coculture and a 4.3 ± 1.62- and 3.47 ± 0.98-
fold increases in single and transwell culture, respectively
(Figure 4(a)). In addition, NG2 expression revealed a 3.11 ±
0.64-fold increase for cells in direct coculture, a 2.32 ± 0.55-
fold increase for single culture, and a 1.51 ± 0.34-fold increase
for transwell culture (Figure 4(b)).
An overall decrease in gene expression of 𝛼SMA and
PDGFR-𝛽 was observed in MSCs after 3 days when cultured
in IMDMFCS (Figures 4(c) and 4(d)).The 2−ΔΔCt values (day
3/day 0) of PECAM-1 decreased in MSCs for all conditions
(Figure 4(e)).
EPCs in IMDM-PL showed an upregulation of CD146
and NG2 at day 3 in all culture setups. In contrast to MSCs,
EPCs showed the lowest upregulation in direct coculture with
MSCs in comparison to single or transwell cultures. In detail,
CD146 expression in EPCs direct coculture with MSCs prop-
agated in IMDM-PL showed a 1.7 ± 0.51-fold increase
compared to a 2.13 ± 0.82- and 3.0 ± 0.94-fold increases in
single or transwell culture, respectively (Figure 4(f)). A 1.36±
0.48-fold increase was observed for NG2 expression in EPCs
in coculture with MSCs in IMDM-PL, and a 2.54 ± 1.03- and
3.22 ± 1.48-fold upregulation in single and transwell culture
were observed, respectively (Figure 4(g)).
Gene expression of 𝛼SMA and PDGFR-𝛽 in EPCs was
likewise not affected by the different cell-culture setups. Both
genes were downregulated at day 3 without significant differ-
ences between culture conditions (Figures 4(h) and 4(i)).
Noteworthy, a 10.2 ± 5.94-fold increase of PECAM-1 was
observed in EPCs in direct coculture with MSCs in IMDM-
PL. PECAM-1 expression of EPCs was of lesser extent in
single and transwell culture, with a 1.12 ± 0.40- and 2.53 ±
0.89-fold increase, respectively (both > 0.05) (Figure 4(j)).
3.4. MSCs in Direct Coculture Coexpress CD146, 𝛼SMA, and
NG2. Expression of the PC markers CD146, 𝛼SMA, and
NG2, were detected by immunofluorescence staining on
MSCs after 7 days when cocultured with EPCs and consecu-
tive separation. Single positive and double positive cells were
detectable, in both IMDM-FCS and IMDM-PL (Figure 5).
4. Discussion
The aim of the present study was to investigate the interac-
tions between EPCs and MSCs in cocultures to determine
the origin of PC-like cells in vitro. In addition, we evaluated
the influence of platelet derived growth factors on EPCs and
MSCs in this experimental setup.
In our previous work, we successfully established a 3D
prevascularised scaffold in vitro [10]. We demonstrated a
beneficial effect of MSCs coseeded with EPCs and observed
the formation of luminal tubular structures already after 7
days in vitro. Notably, tubular structures were positive for
CD146, NG2, and 𝛼SMA, suggesting the presence of PC-like
cells.
In the present study, MSCs and EPCs were cultured in
direct contact or in a transwell system to elucidate the influ-
ence of soluble, paracrine factors and to identify the popula-
tion of origin of in vitro differentiated PCs.
It is well accepted that CD34 and CD133 are EPCmarkers
[6]. In contrast to EPC, PCs do not express CD34 and CD133;
however, they do express CD146 [13, 14, 25]. Therefore, we
assume that the depleted-MSC cell population, characterised
by the absence of CD34, CD133, or CD146, is free of EPCs and
CD146+ PCs.
This was confirmed by gene expression analysis of
depleted-MSCs at day 0, which was similar to the profile
obtained for MSCs.
To date, there is no single surface marker that is specific
or exclusively expressed on PCs [26]. However, PCs can be
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Figure 4: Gene regulation in MSCs and EPCs after 3 days of culture in IMDM-PL. Pericyte marker genes CD146 ((a), (f)), NG2 ((b), (g)),
𝛼SMA ((c), (h)), and PDGFR-𝛽 ((d), (i)) and endothelial marker gene PECAM-1 ((e), (j)) were detected in MSCs and EPCs after 3 days in
transwell culture, direct coculture, and single culture in IMDM-PL (IMDM supplemented with 5% FCS and 5% PL). Results are presented
for each gene as relative change in gene expression (2−ΔΔCt) over time between day 0 and day 3 in 5 independent experiments (donor 1–5) and
as average ± error of the mean of all experiments.
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Figure 5: Coexpression of pericyte markers on MSCs after direct coculture with EPCs for 7 days in IMDM-FCS (top row) or IMDM-PL
(bottom row). Immunofluorescence staining for CD146, NG2, and 𝛼SMA demonstrated double positive cells for each combination (CD146
and NG2, CD146 and 𝛼SMA, and NG2 and 𝛼SMA). Negative controls were stained only with the fluorescent labelled secondary antibody.
Cell nuclei are stained with DAPI (blue). Scale bars = 50𝜇m.
identified by coexpressing CD146 [13, 14], NG2 [15], 𝛼SMA
[16], and PDGFR-𝛽 [17] while being negative for PECAM-1
[7]. We observed a remarkable increase of CD146 and NG2
expression on MSCs and depleted-MSCs when cocultured
with EPCs. PDGFR-𝛽 expression decreased but was still
the highest expressed gene of all examined PC markers.
Analysing the gene expression after different days of cocul-
ture, we found the most prominent differential regulation of
genes on day 3.The increasedCD146 andNG2 expression, the
maintained high expression of PDGFR-𝛽, and the complete
reduction of PECAM-1 inMSCs and depleted-MSCs support
the assumption that MSCs and depleted-MSCs differentiate
towards a PC-like phenotype.
In addition, the gene expression of depleted-MSCs and
MSCs revealed similar results, indicating that CD146 positive
cells present in MSCs did not proliferate. This underlines the
hypothesis that MSCs and depleted-MSCs can differentiate
towards a PC phenotype. In line, immunocytochemistry
revealed positive signals of CD146,NG2, and𝛼SMAonMSCs
which indicates the presence of triple positive cells after 7 days
of direct coculture. Interestingly, the immunofluorescence
analysis demonstrated a positive signal for 𝛼SMA at day 7,
whereas the mRNA level was already decreased at this time
point (data not shown).
We reported the highest upregulation of CD146 and
NG2 for MSCs and depleted-MSCs in direct coculture with
EPC. Therefore, direct cell-cell contact with EPCs might
be an important factor for the differentiation of MSCs and
depleted-MSCs towards a PC-like phenotype.The underlying
mechanism remains unknown. However, integrins may be
involved in this promotion of the angiogenic response of
endothelial cells since the 𝛼6 integrin subunit in MSCs has
been reported to play a role in vessel formation and PC
differentiation [27].
PCs were originally described to be indistinguishable in
culture from MSCs [28]. Covas et al. demonstrated a similar
gene expression profile of retinal PCs compared to MSCs
from 12 different fetal and adult tissues [13], highlighting
the close relationship of both cell populations. Therefore,
Covas et al. suggested that MSCs and PCs might be related
cells, present at the vascular wall, and constitute a MSC
compartment extending throughout the entire organism [13].
The large overall similarity between PCs and MSCs, with
regard to their immunophenotype and differentiation poten-
tial in vitro, was already described by Shi and Gronthos and
Armulik et al. [29, 30]. This supports our hypothesis that
MSCs and depleted-MSCs differentiate towards a PC-like
phenotype.
Armulik et al. noted that the expression of the combina-
tion of markers which were used to confirm the PC pheno-
type in our study is variable and depends on culture condi-
tions [26]. We used two media conditions based on IMDM.
MEM𝛼 was used for MSCs/depleted-MSCs expansion prior
to the experiment. Armulik et al. demonstrated a strong NG2
expression of human placenta derived PCs when cultured
in PC growth media (PGM, Promocell); however, staining
intensity decreased after transfer to Dulbecco’s Modified
Eagle Medium (DMEM). In contrast to this finding, 𝛼SMA
staining was enhanced for both human placenta derived
PCs and MSCs when cultured in DMEM. This emphasises a
crucial, but still unknown, impact of culture conditions.
CD133+ and CD34+ separated cells were highly purified
in our study, but these antigens are not expressed on mature
endothelial cells [8, 31]. On mRNA level, the investigated
EPCs lack the marker of mature endothelial cells PECAM-
1 at the beginning. However, lectin positive cells showed a
significant increase of PECAM-1 expression. Aguirre et al. [4]
reported an upregulation of the endothelial phenotype in
EPCs and MSCs after 3 days of direct coculture without any
supplementary growth factors. Our data support that EPCs
can differentiate into mature ECs by direct cell-cell contact
with MSCs. However, in the present study, cocultured EPCs
were separated by lectin binding, which favours an additional
purification of endothelial cells from a more heterologous
EPCs population.
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Previous studies showed a positive effect on proliferation
and differentiation of endothelial cells treated with growth
factors released by PL [23, 32]. Our data support these
findings, since PECAM-1 expression of EPCs is higher in
IMDM-PL than in IMDM-FCS. Furthermore, we observed
that PL diminished the difference in gene expression for
all PC genes, in both MSCs/depleted-MSCs and EPCs. PL
consists of a composition of growth factors and cytokines,
which might be responsible for the reported changes in the
gene expression.
Interestingly, PECAM-1 expression seems to be partic-
ularly influenced by PL, since PECAM-1 expression is
increased in most cell culture conditions in IMDM-PL
whereas only in direct cocultures in IMDM-FCS. Therefore,
PL might be a trigger for the differentiation of EPCs towards
ECs. More recently, a study demonstrated the importance
of PDGF and EGF signalling in controlling PC recruitment
to luminal tubular structures [33]. Although we have not
explicitly examined these signalling molecules in the present
study, future work can determine if PL influences these
pathways in the same way.
5. Conclusion
In summary, we report preliminary data on the effect of cell-
cell contact of bone marrow derived MSCs and EPCs with
regard to the induction of PC-like cells. The upregulation of
several PCmarker genes (CD146, NG2, and 𝛼SMA) indicates
the differentiation of MSCs/depleted-MSCs towards PCs in
vitro. The change of phenotype is detectable as early as day 3
of coculture.
Moreover, our data confirm that several growth factors,
released by PL, contribute to the differentiation of EPCs
towards endothelial cells. The effect of PL on PC induction
may be further evaluated in future studies. These findings
emphasise the concept of coculture strategies to promote
angiogenesis for cell-based tissue engineered bone grafts.
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